These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17853425)

  • 1. The impact of missing data and how it is handled on the rate of false-positive results in drug development.
    Barnes SA; Mallinckrodt CH; Lindborg SR; Carter MK
    Pharm Stat; 2008; 7(3):215-25. PubMed ID: 17853425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets.
    Siddiqui O; Hung HM; O'Neill R
    J Biopharm Stat; 2009; 19(2):227-46. PubMed ID: 19212876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMRM versus MI in dealing with missing data--a comparison based on 25 NDA data sets.
    Siddiqui O
    J Biopharm Stat; 2011 May; 21(3):423-36. PubMed ID: 21442517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches.
    Lane P
    Pharm Stat; 2008; 7(2):93-106. PubMed ID: 17351897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA.
    Mallinckrodt CH; Kaiser CJ; Watkin JG; Molenberghs G; Carroll RJ
    Clin Trials; 2004; 1(6):477-89. PubMed ID: 16279288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials.
    Mallinckrodt CH; Raskin J; Wohlreich MM; Watkin JG; Detke MJ
    BMC Psychiatry; 2004 Sep; 4():26. PubMed ID: 15355546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating treatment effects from longitudinal clinical trial data with missing values: comparative analyses using different methods.
    Houck PR; Mazumdar S; Koru-Sengul T; Tang G; Mulsant BH; Pollock BG; Reynolds CF
    Psychiatry Res; 2004 Dec; 129(2):209-15. PubMed ID: 15590048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of results from different imputation techniques for missing data from an anti-obesity drug trial.
    Jørgensen AW; Lundstrøm LH; Wetterslev J; Astrup A; Gøtzsche PC
    PLoS One; 2014; 9(11):e111964. PubMed ID: 25409438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of methods for analysis of repeated binary responses with missing data.
    Frank Liu G; Zhan X
    J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dealing with missing data in a multi-question depression scale: a comparison of imputation methods.
    Shrive FM; Stuart H; Quan H; Ghali WA
    BMC Med Res Methodol; 2006 Dec; 6():57. PubMed ID: 17166270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-parametric and non-parametric methods for clinical trials with incomplete data.
    O'Brien PC; Zhang D; Bailey KR
    Stat Med; 2005 Feb; 24(3):341-58. PubMed ID: 15547952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marginal analysis of incomplete longitudinal binary data: a cautionary note on LOCF imputation.
    Cook RJ; Zeng L; Yi GY
    Biometrics; 2004 Sep; 60(3):820-8. PubMed ID: 15339307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can I deal with missing data in my study?
    Bennett DA
    Aust N Z J Public Health; 2001 Oct; 25(5):464-9. PubMed ID: 11688629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for addressing missing data in psychiatric and developmental research.
    Croy CD; Novins DK
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1230-40. PubMed ID: 16292114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the outcome for imputation of missing predictor values was preferred.
    Moons KG; Donders RA; Stijnen T; Harrell FE
    J Clin Epidemiol; 2006 Oct; 59(10):1092-101. PubMed ID: 16980150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods.
    Girardi P; Pompili M; Innamorati M; Mancini M; Serafini G; Mazzarini L; Del Casale A; Tatarelli R; Baldessarini RJ
    Hum Psychopharmacol; 2009 Apr; 24(3):177-90. PubMed ID: 19229839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing response profiles from incomplete longitudinal clinical trial data under regulatory considerations.
    Mallinckrodt CH; Clark SW; Carroll RJ; Molenbergh G
    J Biopharm Stat; 2003 May; 13(2):179-90. PubMed ID: 12729388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of missing data in a generalized integer-valued autoregression model for count data.
    Alosh M
    J Biopharm Stat; 2009 Nov; 19(6):1039-54. PubMed ID: 20183463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.